A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.

Бібліографічні деталі
Автор:	Choki, Kinley
Інші автори:	Chowdhury, Namara Mariam
Формат:	Дисертація
Мова:	English
Опубліковано:	Brac University 2024
Предмети:	Acute lymphoblastic leukemia Leukemia R/R B-cell precursor ALL FDA Blood cancer Lymphoblastic leukemia. Cancer > Immunotherapy. Monoclonal antibodies > Therapeutic use.
Онлайн доступ:	http://hdl.handle.net/10361/24298

Схожі ресурси

Vision Transformer (ViT) approach in computer aided diagnosis of acute lymphoblastic leukemia
за авторством: Amin, Sifatul, та інші
Опубліковано: (2023)

Identification of childhood leukemia using deep learning
за авторством: Tultul, Farana Naz
Опубліковано: (2018)

Detection of acute Lymphocytic Leukemia (ALL) and its type by image processing and machine learning
за авторством: Chowdhury, Himadri, та інші
Опубліковано: (2019)

Stem cell in cancer disease cure vs cause
за авторством: Chowdhury, Marisha Mansur
Опубліковано: (2023)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
за авторством: Khan, Muidul Hasan
Опубліковано: (2024)

Comparative analysis of neural network Models for peripheral blood cell image classification
за авторством: Mollah, Md Tanzid, та інші
Опубліковано: (2024)

Immunotherapeutic approaches to treat cancer: Prospects and challenges
за авторством: Fred, Namanda Rogers
Опубліковано: (2021)

Advancement of Antibody-Drug conjugates in cancer treatment: A review
за авторством: Sagar, Baejid Hossain
Опубліковано: (2022)

Concepts and challenges of biosimilars to mitigate the oncology drug expenses
за авторством: Tania, Umme
Опубліковано: (2021)

Immunotherapy in the Management of Lung Cancer
за авторством: Tasnim, Humayra
Опубліковано: (2022)

Current practice and approaches of immunotherapy in Cancer treatment
за авторством: Khondokar, Faiza
Опубліковано: (2022)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
за авторством: Abir, Shifaty Nur
Опубліковано: (2024)

A review on targeted therapies for lung cancer
за авторством: Ashraf, Anushey
Опубліковано: (2023)

The Rainmaker
Опубліковано: (1995)

The rainmaker /
за авторством: Grisham, John
Опубліковано: (1995)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
за авторством: Rahman, Sanjida
Опубліковано: (2024)

CAR-T cell Therapy in B-cell Lymphoma
за авторством: Faruk, Asef
Опубліковано: (2020)

In vivo propagation of monoclonal antibodies in ascites fluid produced in BALB/c mice: characterization and diagnostic application for the identification of Vibrio cholerae O1
за авторством: Chowdhury, Mashiat Nawar
Опубліковано: (2018)

Trend in approval of targeted biologics in the last two decades
за авторством: Siddika, Khadiza
Опубліковано: (2024)

Role of toll-like receptors in cancer immunotherapy– a review
за авторством: Khan, Rezia Nowrin
Опубліковано: (2021)

Osteoarthritis: a multi-disciplinary factual review
за авторством: Subah, Nowshin
Опубліковано: (2021)

A study of Osteosarcoma gene profile
за авторством: Arka, Sadib Md.
Опубліковано: (2022)

Study on anticancer drugs approved by the FDA from 2014 to 2023
за авторством: Rattry, Faria Rahman
Опубліковано: (2024)

A review paper on Nanotechnology based strategies in the treatment of cancer
за авторством: Rahman, Samia
Опубліковано: (2022)

Bioinformatics Analysis Reveals miR-98-5p as a potential Inhibitor of Tumor cell proliferation and metastasis in Colorectal Cancer by targeting the FZD3 receptor of the Wnt signaling pathway
за авторством: Kenneth, Mutebi John
Опубліковано: (2022)

Nanomaterials for diagnosis and treatment of brain cancer
за авторством: Tonny, Tamanna Shahrin
Опубліковано: (2024)

Dendritic cell vaccine for the treatment of cancer
за авторством: Haque, Tanzila
Опубліковано: (2023)

Statistics and informatics in molecular cancer research

S. R Trading Ltd.
за авторством: Swarna, Yasmeen Haque
Опубліковано: (2017)

IEEE R10 technical seminar at BRAC University
за авторством: Rafique, Rumana
Опубліковано: (2015)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
за авторством: Ratu, Tabassum
Опубліковано: (2024)

Post Covid-19 health indications of Covid-19 patients
за авторством: Khan, Tanzim
Опубліковано: (2022)

Recent advancement of biologics in Asthma
за авторством: Evan, Al- Shahriar
Опубліковано: (2022)

Immunotherapy in the treatment of renal cancer
за авторством: Shimu, Sumaya
Опубліковано: (2022)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
за авторством: Bristy, Israt Zerin
Опубліковано: (2021)

Cancer risk factors: a critical review
за авторством: Tabassum, Tahsina
Опубліковано: (2017)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
за авторством: Nawar, Anika
Опубліковано: (2019)

Targeting BRAFV600E in the treatment of CRC
за авторством: Roja, Mashwiyat Samrin
Опубліковано: (2024)

Oral terbinafine-, fluconazole-, ravuconazole-, oteseconazole-induced hepatotoxicity and acute kidney injury in the treatment of onychomycosis: a pharmacovigilance study
за авторством: Rahman, Towsifur
Опубліковано: (2024)

Role of statins as antagonists of SPARC in gastric cancer
за авторством: Shahmat, Rad
Опубліковано: (2019)